China Pharma (CPHI) had the highest return between February 28, 2024 and March 20, 2024 by a US stock in the Pharmaceuticals Industry, returning 374.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
China Pharma (CPHI) | 2/28/2024 - 3/20/2024 | 374.86% |
Adial Pharmaceuticals (ADIL) | 2/28/2024 - 3/20/2024 | 69.9% |
SIGA Technologies (SIGA) | 2/28/2024 - 3/20/2024 | 63.32% |
Elicio Therapeutics (ELTX) | 2/28/2024 - 3/20/2024 | 60.19% |
KING PHARMACEUTICALS (KG) | 2/28/2024 - 3/20/2024 | 50.39% |
Aquestive Therapeutics (AQST) | 2/28/2024 - 3/20/2024 | 36.52% |
Cns Pharmaceuticals (CNSP) | 2/28/2024 - 3/20/2024 | 33.54% |
Jaguar Animal Health (JAGX) | 2/28/2024 - 3/20/2024 | 33.33% |
Durect (DRRX) | 2/28/2024 - 3/20/2024 | 30.61% |
Canopy Growth (CGC) | 2/28/2024 - 3/20/2024 | 28.61% |
Trevi Therapeutics (TRVI) | 2/28/2024 - 3/20/2024 | 25.53% |
Assertio Therapeutics (ASRT) | 2/28/2024 - 3/20/2024 | 25.3% |
Avadel Pharmaceuticals (AVDL) | 2/28/2024 - 3/20/2024 | 24.96% |
Wave Life Sciences (WVE) | 2/28/2024 - 3/20/2024 | 23.11% |
Supernus Pharmaceuticals (SUPN) | 2/28/2024 - 3/20/2024 | 22.04% |
MIRA Pharmaceuticals, Inc Common Stock (MIRA) | 2/28/2024 - 3/20/2024 | 21.57% |
Clearside Biomedical (CLSD) | 2/28/2024 - 3/20/2024 | 19.85% |
Iterum Therapeutics (ITRM) | 2/28/2024 - 3/20/2024 | 19.7% |
Hoth Therapeutics (HOTH) | 2/28/2024 - 3/20/2024 | 17.74% |
Aurora Cannabis (ACB) | 2/28/2024 - 3/20/2024 | 17.07% |
Nektar Therapeutics (NKTR) | 2/28/2024 - 3/20/2024 | 16.88% |
Perrigo (PRGO) | 2/28/2024 - 3/20/2024 | 15.75% |
ANI Pharmaceuticals (ANIP) | 2/28/2024 - 3/20/2024 | 14.34% |
Ventyx Biosciences (VTYX) | 2/28/2024 - 3/20/2024 | 13.64% |
OrganiGram (OGI) | 2/28/2024 - 3/20/2024 | 13.08% |
